#LCSM Transcript

Healthcare social media transcript of the #LCSM hashtag.
().
See #LCSM Influencers/Analytics.

ProfileTweet
Janet Freeman-Daily @JFreemanDaily
Welcome to #LCSM Chat! Tonight we will be discussing “Expanding Access to Cancer Clinical Trials.” More info on our blog at https://t.co/KBsE6cSmaG
Tiffini Joseph @Smiles4Nana
RT @JFreemanDaily: Welcome to #LCSM Chat! Tonight we will be discussing “Expanding Access to Cancer Clinical Trials.” More info on our blog…
Janet Freeman-Daily @JFreemanDaily
I’m your moderator Janet Freeman-Daily (writer, science geek, #lungcancer patient/research advocate). With me is tonight’s special guest Stacey Tinianov ([REDACTED USER]), #breastcancer patient/research advocate extraordinaire. Welcome Stacey! #LCSM
The Kidney Project @KidneyProject
March 12, 2020 is World Kidney Day World Kidney Day is aimed at raising awareness of the importance of our kidneys. ⁠Join us: Facebook: https://t.co/IX8VQ32m0b Instagram: https://t.co/efFXUQrXjf Give a gift: https://t.co/sESScGZlx0 #TKP#KidneyDisease #WorldKidneyDay https://t.co/nE3EZ36OjF
Janet Freeman-Daily @JFreemanDaily
We'll get started in a few minutes -- please take a moment to introduce yourselves #LCSM
@KimballKristen
@JFreemanDaily [REDACTED USER] It’s Kris, signing in properly this time w/ hashtag #LCSM, still from Boston!
Alicia C. Staley @stales
RT @JFreemanDaily: Welcome to #LCSM Chat! Tonight we will be discussing “Expanding Access to Cancer Clinical Trials.” More info on our blog…
Tiffini Joseph @Smiles4Nana
Tiffini Joseph joining from south Florida. Hi everyone #LCSM
Janet Freeman-Daily @JFreemanDaily
@KimballKristen [REDACTED USER] Welcome Kris! #LCSM Glad you could join us.
Alicia C. Staley @stales
@JFreemanDaily Hi there! Alicia - 3x cancer survivor, co-founder of #BCSM checking in to say hi and watch the chat. Great topic! #LCSM
Janet Freeman-Daily @JFreemanDaily
My usual sidekick @LungCancerFaces is busy with grandmotherly duties tonight, so I'm grateful Stacey is my copilot tonight. #LCSM
Sara Whitlock @sjwhitlock
Sara here. Working on 10 years with stage IV NSCLC! #LCSM
Cori @coristarlit
@JFreemanDaily [REDACTED USER] Cori here, joining from Northern CA! #LCSM
Janet Freeman-Daily @JFreemanDaily
Hi Tiffini, Christine and Alicia! Thanks for dropping in. #LCSM
Alicia C. Staley @stales
[REDACTED USER] @JFreemanDaily hey there! how are you. #LCSM
Janet Freeman-Daily @JFreemanDaily
Welcome Cori and Sara! #LCSM
Peggy Dennis @peggyddennis
Peggy here from Denver. Waiting on biopsy results to determine eligibility for 3 clinical trials @ UCH #lcsm
Janet Freeman-Daily @JFreemanDaily
@stales [REDACTED USER] Rolling with the evolving #COVID19Seattle situation. #LCSM
Janet Freeman-Daily @JFreemanDaily
Hi Peggy! #LCSM
Janet Freeman-Daily @JFreemanDaily
If you are new to Twitter chats and/or #LCSM Chat, you might find our primer on how to participate helpful https://t.co/5g28sSQQLb
Janet Freeman-Daily @JFreemanDaily
Please remember to use #lcsm in all your tweets so others participating in the chat can see them. #LCSM
Laura Greco @lgreco_ny
Greetings from upstate NY! #lcsm
Janet Freeman-Daily @JFreemanDaily
I will announce FOUR topics (T1 T2 etc). Pls label your answers with T1, T2, etc to make transcript easier to follow. #LCSM
Janet Freeman-Daily @JFreemanDaily
We’ll start with Topic T1 in a minute …#LCSM
Janet Freeman-Daily @JFreemanDaily
@lgreco_ny Hi Laura! #LCSM
Janet Freeman-Daily @JFreemanDaily
T1. What are the barriers to cancer clinical trial participation and enrollment? #LCSM
Sara Whitlock @sjwhitlock
T1. Admission criteria. #LCSM
Inspire @InspireIsHealth
Hi all, John Novack from Inspire checking in to #LCSM.
Janet Freeman-Daily @JFreemanDaily
[REDACTED USER] Hey Lillian! Welcome. #LCSM
Inspire @InspireIsHealth
RT @JFreemanDaily: T1. What are the barriers to cancer clinical trial participation and enrollment? #LCSM
Laura Greco @lgreco_ny
@JFreemanDaily T1: I think time and money are two big ones. #lcsm
Janet Freeman-Daily @JFreemanDaily
#Clinicaltrials aim to understand the risks and benefits of a treatment in a specific population or disease. Hopefully the results can be applied to all who have the disease. #LCSM https://t.co/I8LdPSzNfK
Tiffini Joseph @Smiles4Nana
So, I just switched careers and now am a LC research RN. So far, The inclusion/exclusion criteria can be so tight #LCSM
Alicia C. Staley @stales
RT @JFreemanDaily: #Clinicaltrials aim to understand the risks and benefits of a treatment in a specific population or disease. Hopefully t…
Janet Freeman-Daily @JFreemanDaily
Hi John and Narjust! #LCSM
@KimballKristen
T1 I expect some barriers include lack of knowledge on part of patient, perhaps even physician; distance from major research centers where trials are held; and false perception that they “could get the placebo” #LCSM
Tiffini Joseph @Smiles4Nana
T1 and not enough referrals to studies #LCSM
Narjust Florez, MD, FASCO @NarjustFlorezMD
@JFreemanDaily A1: Strict and at times no evidence based eligibility criteria. Here is the link to our study regarding this, particularly in early phase studies. https://t.co/QoLrV4aVNo #LCSM
Janet Freeman-Daily @JFreemanDaily
Globally, about 3/4 of people surveyed were willing to participate in a clinical trial, yet only 8% of adult US cancer patients participate in NCI or industry clinical trials. Why?#LCSM
Alicia C. Staley @stales
Please join in #LCSM chat going on now.
Alicia C. Staley @stales
RT @JFreemanDaily: T1. What are the barriers to cancer clinical trial participation and enrollment? #LCSM
Janet Freeman-Daily @JFreemanDaily
Patients site many reasons for not participating in clinical trials #LCSM https://t.co/yZjD7tZLsJ
Janet Freeman-Daily @JFreemanDaily
RT @NarjustDumaMD: @JFreemanDaily A1: Strict and at times no evidence based eligibility criteria. Here is the link to our study regarding…
Laura Greco @lgreco_ny
@Smiles4Nana Yes! Too often, doctors only will refer to trials within their institution. It happened to me more than once. #lcsm
Janet Freeman-Daily @JFreemanDaily
A study by Unger found that more than half of all cancer patients did not participate in #clinicaltrials because no trial was available. #LCSM
Peggy Dennis @peggyddennis
#Ditto on inclusion/exclusion. Patient numbers for enrollment can be too small #lcsm
Sara Whitlock @sjwhitlock
So many think it is last ditch option #LCSM
Narjust Florez, MD, FASCO @NarjustFlorezMD
@JFreemanDaily @LungCancerFaces @LungCancerFaces grandmother duties are so important. I am who I am today thanks to my grandma. Also something unique to women with lung cancer, they are more likely to be a source of childcare/elderly compare to men. #LCSM
Inspire @InspireIsHealth
RT @JFreemanDaily: Patients site many reasons for not participating in clinical trials #LCSM https://t.co/yZjD7tZLsJ
Janet Freeman-Daily @JFreemanDaily
Patients with rare diseases may spend a long time searching for a clinical trial that will accept them. https://t.co/FuJS6NtdMw #LCSM
Janet Freeman-Daily @JFreemanDaily
Topic T2 is coming up … #LCSM
Tiffini Joseph @Smiles4Nana
T1: not enough patient reimbursement for copays when providing standard of care, travel expenses etc... #LCSM
Alicia C. Staley @stales
RT @JFreemanDaily: A study by Unger found that more than half of all cancer patients did not participate in #clinicaltrials because no tria…
Cori @coristarlit
@JFreemanDaily I think Geography and finances are two biggest reasons. For those who don’t live close to the institution that is doing the clinical trial, it is going to cost an arm and a leg to participate. #LCSM
Janet Freeman-Daily @JFreemanDaily
Barriers to clinical trials may be structural (finding an available trial where the patient is able to go), clinical (patient characteristics must meet eligibility requirements), physician-based (discussing/offering trials), or patient-based (concerns about enrollment). #LCSM
Janet Freeman-Daily @JFreemanDaily
T2. How might awareness of clinical trials be increased?#LCSM
Boots to Grasses @bootstograsses
That's one cute cowboy!#downsyndrome #eaat #ohiotherapeutic #differentnotless #diversity #autism #depressionhelp #bipolardisorder #recovery #spasticcerebralpalsy #preemiestrong #kindness #autismacceptancehttps://t.co/YLRqRLzWio
Participatory Medicine @S4PM
RT @ePatientDave: Love it! "Help me see the dragon I'm slaying": pathologists meeting w patients, in @ArchivesPath. @S4PM Blog @Wellforce
Laura Greco @lgreco_ny
T1: Time it takes to get onto trial could matter too. It took more than three weeks to get on mine and I was worried. Some may not be able to wait. #lcsm
Peggy Dennis @peggyddennis
T2 Make it easier for patients to find clinical trials via web sites that specialize in C/T's. Then offer help with followthrough. #lcsm
Tiffini Joseph @Smiles4Nana
It would be nice if there was a registry that oncologists could participate in that could identify some basic qualifying factors for referral/notification to study centers #LCSM
@KimballKristen
@lgreco_ny and if the trial requires a long washout period from former treatment, that is frightening #LCSM
Cori @coristarlit
Whoops. Forgot #LCSM tag
Laura Greco @lgreco_ny
T2: I think patient testimonials can be quite powerful. #lcsm
Showtime @withspin
RT @JFreemanDaily: A study by Unger found that more than half of all cancer patients did not participate in #clinicaltrials because no tria…
Janet Freeman-Daily @JFreemanDaily
@coristarlit Yep, that #LCSM tag really helps those of us in the chat see your tweets!
Tiffini Joseph @Smiles4Nana
Agree!!
Alicia C. Staley @stales
RT @coristarlit: Whoops. Forgot #LCSM tag https://t.co/7LNoNNHuyC
Laura Greco @lgreco_ny
RT @KimballKristen: @lgreco_ny and if the trial requires a long washout period from former treatment, that is frightening #LCSM
Lecia Sequist, MD, MPH @LeciaSequist
#LCSM joining late from Boston
Cori @coristarlit
@JFreemanDaily T2. I don’t know if awareness is a problem. I think most patients know clinical trials are out there, but they assume their doctor will tell them its an option. Many don’t realize that if a trial isn’t at that doctors hospital, it is very likely they don’t know about it. #LCSM
@akknowles1
@UppityCancerP I always say too bad Buddha didn’t get cancer. It would have saved him a lot of time. You get cancer and are automatically enlightened. #cancer #bcsm #LCSM
Janet Freeman-Daily @JFreemanDaily
Alas, #LCSM Chat retweets from @lcsmchat account are languishing without the nimble fingers of @LungCancerFaces... #LCSM
@DavidCookeMD
A2 I think some of the cultural barriers should be addressed. For instance, many in the African-American communities are reluctant to participate in CT because of the Tuskegee syphilis debacle. #LCSM
Lecia Sequist, MD, MPH @LeciaSequist
@Smiles4Nana Such a resource exists (https://t.co/tRPn2C2DNo) but unfortunately it's not as user-friendly as one might wish #LCSM
Janet Freeman-Daily @JFreemanDaily
Thanks for sharing that link, [REDACTED USER]! #Cancer patient advocates, send your suggestions in SOON! #LCSM
@KimballKristen
T2 Outreach should address the fact that, at least for #lungcancer , clinical trials are NOT the “last option” but may very well be the first. #LCSM
Sara Whitlock @sjwhitlock
@LeciaSequist @Smiles4Nana Yes. I think you have to really work to find what you are looking for. But aren’t they revamping the site?T2
Janet Freeman-Daily @JFreemanDaily
@LeciaSequist Welcome Lecia! And apologies to any I've neglected to welcome. #LCSM
Tiffini Joseph @Smiles4Nana
@LeciaSequist Yes, more user friendly. Something simple. Pt has dx, entered into system and study nurse is alerted. Even if not large scale. Would be helpful in center participating in trials. There are many patients that still don’t get referred #LCSM
Janet Freeman-Daily @JFreemanDaily
We’ll shift to Topic T3 next … #LCSM
Laura Greco @lgreco_ny
@LeciaSequist @Smiles4Nana It is also frequently wrong and out of date. That search engine needs to change! #lcsm
Janet Freeman-Daily @JFreemanDaily
RT @LeciaSequist: @Smiles4Nana Such a resource exists (https://t.co/tRPn2C2DNo) but unfortunately it's not as user-friendly as one might wi…
Laura Greco @lgreco_ny
RT @JFreemanDaily: Thanks for sharing that link, [REDACTED USER]! #Cancer patient advocates, send your suggestions in SOON! #LCSM
Janet Freeman-Daily @JFreemanDaily
@DavidCookeMD Hey there @DavidCookeMD! #LCSM
Janet Freeman-Daily @JFreemanDaily
T3. How might eligibility requirements be modernized to help increase clinical trial enrollment? #LCSM
Sara Whitlock @sjwhitlock
T2. Aren’t they revamping the clinical trial site? #LCSM
@DavidCookeMD
Ola! #LCSM
@DavidCookeMD
A3, remove the "other solid organ tumor within 5 years" exclusion. #LCSM
Laura Greco @lgreco_ny
[REDACTED USER] @LeciaSequist @Smiles4Nana @nlm_news Do you have a sample template of comments? #lcsm
Janet Freeman-Daily @JFreemanDaily
Did you know that even when a clinical trial is available, 21.5% patients are ineligible due to exclusion criteria? #LCSM https://t.co/uZvpxZyhKI
Sara Whitlock @sjwhitlock
@JFreemanDaily Not shocked AT ALL!#LCSM
Janet Freeman-Daily @JFreemanDaily
3 common characteristics (history of cancer, brain mets, high creatinine) can exclude almost half of advanced-stage NSCLC patients from clinical trials. Broadening these eligibility criteria would make almost twice as many patients eligible. #LCSM https://t.co/9sGA6r8p8j
Alicia C. Staley @stales
RT @JFreemanDaily: Did you know that even when a clinical trial is available, 21.5% patients are ineligible due to exclusion criteria? #LC
Laura Greco @lgreco_ny
Yes! #lcsm
@DavidCookeMD
Agree. I believe many trials are loosening the creatinine restrictions. #LCSM
Janet Freeman-Daily @JFreemanDaily
As science advances, trials are becoming more complex. The number of exclusion criteria in #lungcancer clinical trials has been increasing. #LCSM https://t.co/sAGxPSyMP1
Lecia Sequist, MD, MPH @LeciaSequist
@JFreemanDaily @Lungevity has done so much great advocacy to push pharma and FDA on this front. Things like not excluding pts w/ a h/o another cancer, with brain mets. They are working on remote consenting now #LCSM
patty spears @paspears88
@JFreemanDaily My favorite figure from this paper...an aha moment in a graph. Patients aren't the issue, the system needs to change and trials need to include more patients. #lcsm
Cori @coristarlit
@wi_qiong @JFreemanDaily In my experience there are hundreds of clinical trials out there and 99% of onc’s cannot keep up to date with all of them. Especially since the criteria varies so widely. They do know the trials that they currently have at their own hospital. #LCSM
Laura Greco @lgreco_ny
T3: drop whenever possible the brain met exclusion. #lcsm
Narjust Florez, MD, FASCO @NarjustFlorezMD
@JFreemanDaily A2: the conversation about clinical trials should be discussed included in the majority of patient visits. If we talk about it, we normalize it. #LCSM
Lecia Sequist, MD, MPH @LeciaSequist
This 👇
Janet Freeman-Daily @JFreemanDaily
@LeciaSequist @LUNGevity Some of my charts tonight were provided by the marvelous Upal Basu Roy of @LUNGevity -- thanks buddy. #LCSM
Laura Greco @lgreco_ny
T3: how about trial design with patient input? #lcsm
@DavidCookeMD
A3 There is also geographic disparities. Travel distances to participate in clinical trials. Sometimes patients are forced to move. In those cases, many of course will not any bother. #LCSM
@DavidCookeMD
Or even over the phone translators. #LCSM
Laura Greco @lgreco_ny
T3: Let's design trials by pairing drugs that actually make sense rather than drugs we can get from manufacturer easily. #lcsm
Inspire @InspireIsHealth
RT @JFreemanDaily: Did you know that even when a clinical trial is available, 21.5% patients are ineligible due to exclusion criteria? #LC
@DavidCookeMD
Would require targeted community center partnerships. #LCSM
Harpreet Singh, MD @harpreet_md
@LeciaSequist @JFreemanDaily @LUNGevity @FDAOncology has several guidances out on modernizing eligibility criteria - including patients with brain metastasis abs organ dysfunction. #LCSM
Inspire @InspireIsHealth
RT @JFreemanDaily: T3. How might eligibility requirements be modernized to help increase clinical trial enrollment? #LCSM
Sara Whitlock @sjwhitlock
Few of us who have had multiple treatments are without some organ damage#lcsm
Dr. Heuer @DrLisaHeuer
https://t.co/AkOqxDLWdB #weightlossjourney #weightloss #weightlosstransformation #healthyfood #healthylifestyle #diet #lifestyle #nutrition #childhoodobesity #wellness #eathealthy #mealprep #nyackhttps://t.co/L15aTHRIpc
Showtime @withspin
RT @JFreemanDaily: Patients with rare diseases may spend a long time searching for a clinical trial that will accept them. https://t.co/Fu…
Janet Freeman-Daily @JFreemanDaily
@harpreet_md @LeciaSequist @LUNGevity @FDAOncology @ASCO and Friends of Cancer Research published several reports last year on the modernizing of eligibility criteria. It was the basis of a presentation on relaxing trials eligibility requirements I gave at #WCLC19 last year. #LCSM
Dr. Amy C. Moore @acmoorephd
RT @LungCancerFaces: Why aren’t more cancer patients participating in clinical trials? There are a number of reasons. Let’s identify them &…
patty spears @paspears88
Here is my recent editorial on this topic. I have the Unger and the Harvey articles referenced in it. I also have the @ASCO @CancerResrch modernizing eligibility references in it. All advocates need to become educated about all these issues. https://t.co/UZiX7u6yQ7 #lcsm
@DavidCookeMD
RT @paspears88: Here is my recent editorial on this topic. I have the Unger and the Harvey articles referenced in it. I also have the @AS
Janet Freeman-Daily @JFreemanDaily
This is where you can find all the info on ASCO/Friends of Cancer Research work on modernizing clinical trial eligility. #LCSM
@DavidCookeMD
RT @JFreemanDaily: This is where you can find all the info on ASCO/Friends of Cancer Research work on modernizing clinical trial eligility.…
Janet Freeman-Daily @JFreemanDaily
RT @paspears88: Here is my recent editorial on this topic. I have the Unger and the Harvey articles referenced in it. I also have the @AS
Janet Freeman-Daily @JFreemanDaily
@paspears88 @ASCO @CancerResrch Terrific Patty, thank you! #LCSM
Sally James @jamesian
[REDACTED USER] @wi_qiong @JFreemanDaily This isn't written in especially EASY language, but guide to Phases of clinical trials https://t.co/5Yxgdt1uk1 #healthliteracy #lcsm
patty spears @paspears88
I just saw this on my twitter feed. Appropriate for this discussion. Still open for comments... increasing representation of older adults on clinical trials #lcsm
Sally James @jamesian
[REDACTED USER] @wi_qiong @JFreemanDaily Video version https://t.co/KQB7se3u1H #lcsm
Harpreet Singh, MD @harpreet_md
@LeciaSequist @JFreemanDaily @LUNGevity @FDAOncology Efforts to publish this series of guidances @FDAOncology led by @DrJuliaBeaver #lcsm https://t.co/BDR1Jjaugb
Inspire @InspireIsHealth
RT @paspears88: Here is my recent editorial on this topic. I have the Unger and the Harvey articles referenced in it. I also have the @AS
Janet Freeman-Daily @JFreemanDaily
I would really like to see preclinical data made available to patients for consideration prior to joining a Phase 1 clinical trial. #LCSM
Lecia Sequist, MD, MPH @LeciaSequist
#LCSM words I use to explain to those nervous about clinical trials: while we have lots of treatments for lung CA, we don't have infinite treatments. A trial that makes sense for you opens the door to an additional line of therapy, while also improving info for future pts
Charu Aggarwal, MD, MPH, FASCO @CharuAggarwalMD
@JFreemanDaily A3. Some of the changes that are much needed are coming, inclusion of patients affected with HIV and brain mets #LCSM
Julia Maués @itsnot_pink
RT @paspears88: Here is my recent editorial on this topic. I have the Unger and the Harvey articles referenced in it. I also have the @AS
Tatiana Prowell, MD @tmprowell
[REDACTED USER] @NarjustDumaMD @JFreemanDaily Thanks, friends. xx
Janet Freeman-Daily @JFreemanDaily
And we DEFINITELY need all clinical trial data published--even when it's negative. How can we avoid making the same mistake in the future if we don't know about it? #LCSM
Benjamin Vincent @BenjaminGVincen
RT @paspears88: Here is my recent editorial on this topic. I have the Unger and the Harvey articles referenced in it. I also have the @AS
@DavidCookeMD
A3 Good words. Medical Oncologists are skilled at explaining clinical trials as opposed to surgeons. Not alot of neoadjuvant and adjuvant #LungCancer trials, and patients are skeptical. "Just want it out". #LCSM
Janet Freeman-Daily @JFreemanDaily
5:44 Topic T4 is coming up … #LCSM
@DavidCookeMD
RT @JFreemanDaily: And we DEFINITELY need all clinical trial data published--even when it's negative. How can we avoid making the same mist…
Peggy Dennis @peggyddennis
@JFreemanDaily That would be great! #lcsm
Janet Freeman-Daily @JFreemanDaily
RT @harpreet_md: @LeciaSequist @JFreemanDaily @LUNGevity @FDAOncology Efforts to publish this series of guidances @FDAOncology led by @DrJu
Janet Freeman-Daily @JFreemanDaily
RT @jamesian: [REDACTED USER] @wi_qiong @JFreemanDaily Video version https://t.co/KQB7se3u1H #lcsm
Laura Greco @lgreco_ny
RT @coristarlit: @JFreemanDaily T2. I don’t know if awareness is a problem. I think most patients know clinical trials are out there, but t…
Janet Freeman-Daily @JFreemanDaily
RT @paspears88: I just saw this on my twitter feed. Appropriate for this discussion. Still open for comments... increasing representation…
Julia Maués @itsnot_pink
RT @JFreemanDaily: Did you know that even when a clinical trial is available, 21.5% patients are ineligible due to exclusion criteria? #LC
Laura Greco @lgreco_ny
RT @JFreemanDaily: And we DEFINITELY need all clinical trial data published--even when it's negative. How can we avoid making the same mist…
Lecia Sequist, MD, MPH @LeciaSequist
@JFreemanDaily Agree completely but note in reality this can be a challenge. It can take unbelievable time and energy to get a small negative trial published. May be rewriting many times over for many journals. Whole process can take mult years and many give up mid-stream #LCSM
Janet Freeman-Daily @JFreemanDaily
T4. How might financial, travel, and administrative barriers to clinical trial enrollment be reduced? #LCSM
@DavidCookeMD
Need an open access Journal of Negative Trials. #LCSM
Janet Freeman-Daily @JFreemanDaily
RT @LeciaSequist: @JFreemanDaily Agree completely but note in reality this can be a challenge. It can take unbelievable time and energy to…
patty spears @paspears88
@JFreemanDaily There have been 4 published - Brain Metastasis, Comorbidities, Minimum Age, HIV Inclusion and there are 4 more coming.. #lcsm Kim et. al. PMID: 28968170 Lin et. al. PMID: 28968165 Lichtman et. al. PMID: 28968172 Uldrick et. al. PMID: 28968173  Gore et. al. PMID: 28968169
Janet Freeman-Daily @JFreemanDaily
RT @DavidCookeMD: A3 Good words. Medical Oncologists are skilled at explaining clinical trials as opposed to surgeons. Not alot of neoadj…
Laura Greco @lgreco_ny
@JFreemanDaily The federal government must punish those who fail to report!!! #lcsm https://t.co/YGw9m4nPFA
@DavidCookeMD
A4 Partner with industry: @Airbnb @Uber @lyft #LCSM
Janet Freeman-Daily @JFreemanDaily
RT @LeciaSequist: #LCSM words I use to explain to those nervous about clinical trials: while we have lots of treatments for lung CA, we don…
Percy Lee MD @PercyLeeMD
Through team work @MDAndersonNews #radonc successfully treated our first #thoracic pt with [REDACTED USER] MR-linac. Rewarding to see how a talented team can focus energy to innovate better treatments with advanced technology for our patients. #lcsm @ACKoongMDPhD [REDACTED USER] @jihongw2 https://t.co/od6Pa62CJd
Charu Aggarwal, MD, MPH, FASCO @CharuAggarwalMD
@lgreco_ny Most important. There is significant effort to include pts and advocates in clinical trial design. We must partner Ojibwa this important process #LCSM
Janet Freeman-Daily @JFreemanDaily
@NarjustDumaMD Whatever happened to the Journal of Negative Results? #LCSM
@DavidCookeMD
What's @PCORI is for. #LCSM
Sally James @jamesian
[REDACTED USER] @wi_qiong @JFreemanDaily Another try. #lcsm #clinicaltrials https://t.co/FeJTvCzWMV
Tom Varghese Jr. MD, MS, MBA, FACS, MAMSE 🇺🇸 @TomVargheseJr
RT @JFreemanDaily: And we DEFINITELY need all clinical trial data published--even when it's negative. How can we avoid making the same mist…
@DavidCookeMD
Was that a thing? #LCSM
Sara Whitlock @sjwhitlock
T4. I’m lucky my trial does reimburse me. I don’t understand why this doesn’t happen more. Pharm vs academia? Perhaps? #LCSM
Cori @coristarlit
@JFreemanDaily T4. Reimbursement for travel expenses! It’s ridiculous that we have to shoulder this cost, especially when if we don’t live near it, after years it can be over 10 grand (yes, personal experience here). #LCSM
Charu Aggarwal, MD, MPH, FASCO @CharuAggarwalMD
@JFreemanDaily A4. Clinical trials are attractive when they include fringe benefits- parking, flights, overnight stays. They are important! #LCSM
@KimballKristen
[REDACTED USER] @JFreemanDaily @1111linno Ditto this tweet[REDACTED USER]! Parking, lodging, food... #LCSM
patty spears @paspears88
This was presented @ASCO 2019 by Don Harvey https://t.co/gS0yqsdAhY and https://t.co/PyZYE11EIh Quite incredible comparing traditional and broad eligibility... #lcsm
Laura Greco @lgreco_ny
@KimballKristen [REDACTED USER] @JFreemanDaily @1111linno Every time I talk about it, I am met with disbelief. #lcsm
Narjust Florez, MD, FASCO @NarjustFlorezMD
@CharuAggarwalMD @JFreemanDaily A4: Parking is so often overlooked. #LCSM
Lecia Sequist, MD, MPH @LeciaSequist
@JFreemanDaily Agree but IRB's/ethics boards require informed consent forms to be written at 2nd-4th grade reading level and other comments in this chat ref trial info being too complicated. Answer may be giving supplemental info to savvy patients as appropriate? #LCSM
Cori @coristarlit
@JFreemanDaily T4. Also, ability to get blood tests taken at a local hospital if you are not near the trial hospital. To have to fly or drive a long way to get a CBC done every 4 weeks at the clinical trial hospital is absolutely ridiculous. Massive financial cost and life interference. #LCSM
Janet Freeman-Daily @JFreemanDaily
At its meeting last fall, SACHRP made recommendations about paying clinical trial participants that will hopefully make more IRBs comfortable with allowing clinical trials to pay for parking, give gift cards as thank yous, etc. https://t.co/8HHjmOr36R #LCSM
Janet Freeman-Daily @JFreemanDaily
RT @paspears88: This was presented @ASCO 2019 by Don Harvey https://t.co/gS0yqsdAhY and https://t.co/PyZYE11EIh Quite incredible comparing…
Janet Freeman-Daily @JFreemanDaily
We’re in our final minutes - closing thoughts? #LCSM
@KimballKristen
@JFreemanDaily I hadn’t realized IRBs are part of this problem? #LCSM
Sally James @jamesian
[REDACTED USER] @wi_qiong @JFreemanDaily Here is link to page, a collaborative https://t.co/mkmLuTry81 patient-physician collaborative for lung disease. #lcsm
Sally James @jamesian
@JFreemanDaily The delivery of communication that helps ppl make decisions is itself "health care." Should be paid for and designed carefully. #lcsm #healthliteracy
Laura Greco @lgreco_ny
@sjwhitlock Academia certainly isn't pushing for it. #lcsm
Sara Whitlock @sjwhitlock
As with most things it is a complicated issue. Needs attacks from all sides. #LCSM
Janet Freeman-Daily @JFreemanDaily
If we truly want to address #cancer disparities and achieve true diversity in clinical trial enrollment, we have to consider trial participants' cost of insurance deductibles and copays, travel, childcare, and time away from work. #LCSM
Lecia Sequist, MD, MPH @LeciaSequist
@sjwhitlock Agree financial help is super important for trials. Not all trial sponsors (pharma) offer this - it's a bit random which sponsor and which trials. Also, IRBs (institutional ethics board) have concerns about coercion/enticement which we need to address. Frustrating. Sigh....#LCSM
Janet Freeman-Daily @JFreemanDaily
RT @jamesian: @JFreemanDaily The delivery of communication that helps ppl make decisions is itself "health care." Should be paid for and de…
Laura Greco @lgreco_ny
@JFreemanDaily In the rare disease space, patient related travel costs are reimbursed every time. #lcsm
Janet Freeman-Daily @JFreemanDaily
@KimballKristen Some IRBs are reluctant to approve ANY payment to clinical trial participants for fear they are coercing people to participate. #LCSM
@KimballKristen
My husband @VoicesForUS Dave Kimball was in 3 clinical trials, and one of them was a home run - years of quality life added. Forever grateful and wish as many others as possible could benefit as much. #LCSM
Laura Greco @lgreco_ny
RT @JFreemanDaily: If we truly want to address #cancer disparities and achieve true diversity in clinical trial enrollment, we have to cons…
Peggy Dennis @peggyddennis
Great topic. Would be great to revisit. #lcsm
Laura Greco @lgreco_ny
@JFreemanDaily Yes! Coinsurance and co-pays for extra scans can pinch! #lcsm
Lecia Sequist, MD, MPH @LeciaSequist
@lgreco_ny @sjwhitlock Not true Laura - many of us advocate very hard to pharma for this on behalf of our patients. There are lots of barriers unfortunately (see my other tweet a few min ago) - mainly pharma wanting to pay and IRB concerns #LCSM
@KimballKristen
@JFreemanDaily Frankly that seems disingenuous at best and stupid at worst...#lcsm
Janet Freeman-Daily @JFreemanDaily
Thanks everyone for joining #LCSM Chat today to discuss expanding access to clinical trials! Thanks especially to [REDACTED USER] for being my special guest tonight. See you next month on April 2!
@DavidCookeMD
Awesome! Great work as usual @JFreemanDaily #LCSM
Dermatology Associates of Seattle @doctor_of_skin
How THERMIva Has Forever Changed Feminine Rejuvenation: performed by Janell Bailey, Licensed Master Aesthetician. Who is THERMIva intended for? THERMIva could be a great option if you suffer from urinary… https://t.co/52dHWznbvW
Janet Freeman-Daily @JFreemanDaily
@DavidCookeMD Check out this version: https://t.co/aOHGSAHv54 #LCSM
#LCSM content from Twitter.